Novartis
NVS
#56
Rank
$229.52 B
Marketcap
$115.77
Share price
-0.16%
Change (1 day)
10.03%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Number of shares outstanding for Novartis (NVS)

Number of shares outstanding as of June 2025 : 1,968,000,000

According to Novartis's latest financial reports and stock price the company's current number of shares outstanding is 1,968,000,000. At the end of 2025 the company had 1,968,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Novartis from 2019 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20251.96 B-0.96%
20241.98 B-3.64%
20232.06 B-3.42%
20222.13 B-4.56%
20212.23 B-1.24%
20202.26 B0%
20192.26 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Merck
MRK
2,516,394,128 27.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
5,675,000,000 188.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
2,405,625,000 22.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,467,800,000 25.40%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
2,038,500,000 3.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
1,138,000,000-42.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
2,031,000,000 3.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
1,739,206,000-11.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
3,100,000,000 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK